Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2021

View Archived Issues

Onxeo partners with Institut Curie to study AsiDNA with radiotherapy in pediatric high-grade glioma

Morphine itch comes from neurons, not mast cells

Sinovac's CoronaVac COVID-19 vaccine granted conditional marketing authorization in China

ORIC Pharmaceuticals presents new CD73 inhibitors

Canopy Growth synthesizes cannabinoid CB1 and CB2 receptor ligands

GB005 identifies new BTK inhibitors

King Abdulaziz University describes DPP-IV inhibitors

GenScript discloses new anti-CD47/anti-PD-1 bispecific antibodies

Positive phase II data for VERU-111 in hospitalized COVID-19 patients at high risk for ARDS

Reduction of NK-activating ligand NKG2DL contributes to immune scape in SCLC and neuroblastoma

Study identifies a transcriptional feedback loop regulating fatty acid synthesis in EAC

Rukobia approved in Europe for adults with multidrug-resistant HIV

Phase Ib data presented for DA-1241 patients with type 2 diabetes

Phase I trial shows MB-66 to be acceptable and effective in healthy reproductive women

Ad5-nCoV vaccine meets prespecified primary safety and efficacy criteria for phase III study

Innovent begins pivotal study of IBI-310 with sintilimab for first-line advanced HCC

FDA clears Catapult's IND for phase I trial of CAP-100 in CLL

ImmunoMet Therapeutics set to begin phase I U.S. study of IM-156 in IPF

AVROBIO reports new advances with upgraded gene therapy platform

Jasper Therapeutics presents phase I data for anti-CD117 JSP-191 MAb

Positive interim phase I data presented for COVID-19 vaccine candidate UB-612

KalVista releases phase II data on KVD-900 as oral on-demand treatment for HAE

European Commission approves Inrebic for newly diagnosed and previously treated myelofibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...